http://jcps.bjmu.edu.cn

• Full Papers • Previous Articles     Next Articles

In vivo bioassay to determine the potency of a new erythropoiesis stimulating protein

Dong-Mei Su, Hui-Lin Zhao*, Huan-Zhang Xia   

  1. 1. Schoole of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China
    2. Institute of Research and Development, Shenyang Sunshine Pharmaceutical Company Limited, Shenyang 110027, China
  • Received:2009-06-02 Revised:2009-11-05 Online:2010-01-15 Published:2010-01-15
  • Contact: Hui-Lin Zhao*

Abstract: A simple in vivo bioassay suitable for the routine quality control testing of a new erythropoiesis stimulating protein was developed. Subcutaneous administration of the new erythropoiesis stimulating protein to Balb/c mice in a single dose resulted in a dose-dependent increase in the number of circulating reticulocytes. Within the erythropoiesis stimulating protein dose range of 3.125 to 200 ng per mouse, there is a strong linear relationship between the dose and reticulocyte counts in the treated mice. This linear relationship allows us to determine the biological potency of the testing erythropoiesis stimulating protein preparation relative to a reference standard using parallel line assay. Accuracy, precision, dose variation and blood collection time of this method were analyzed in order to choose doses in the linear range that are suitable for setting up a useful, precise, and economical bioassay.

Key words: Erythropoietin, Erythropoietin, Erythropoiesis stimulating protein, Erythropoiesis stimulating protein, Bioassay, Bioassay, Reticulocyte count, Reticulocyte count, Anemia, Anemia

CLC Number: 

Supporting: